TET2 c.3833C>A ;(p.P1278Q)

Variant ID: 4-106180805-C-A

NM_001127208.2(TET2):c.3833C>A;(p.P1278Q)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes.

Leukemia
Follo, Matilde Y MY; Pellagatti, Andrea A; Armstrong, Richard N RN; Ratti, Stefano S; Mongiorgi, Sara S; De Fanti, Sara S; Bochicchio, Maria Teresa MT; Russo, Domenico D; Gobbi, Marco M; Miglino, Maurizio M; Parisi, Sarah S; Martinelli, Giovanni G; Cavo, Michele M; Luiselli, Donata D; McCubrey, James A JA; Suh, Pann-Ghill PG; Manzoli, Lucia L; Boultwood, Jacqueline J; Finelli, Carlo C; Cocco, Lucio L
Publication Date: 2019-09

Variant appearance in text: TET2: P1278Q
PubMed Link: 30787430
Variant Present in the following documents:
  • Main text
  • 41375_2019_Article_416.pdf
View BVdb publication page



Need for high-resolution Genetic Analysis in iPSC: Results and Lessons from the ForIPS Consortium.

Scientific Reports
Popp, Bernt B; Krumbiegel, Mandy M; Grosch, Janina J; Sommer, Annika A; Uebe, Steffen S; Kohl, Zacharias Z; Plötz, Sonja S; Farrell, Michaela M; Trautmann, Udo U; Kraus, Cornelia C; Ekici, Arif B AB; Asadollahi, Reza R; Regensburger, Martin M; Günther, Katharina K; Rauch, Anita A; Edenhofer, Frank F; Winkler, Jürgen J; Winner, Beate B; Reis, André A
Publication Date: 2018-11-21

Variant appearance in text: TET2: 3833C>A
PubMed Link: 30464253
Variant Present in the following documents:
  • 41598_2018_35506_MOESM5_ESM.xlsx, sheet 4
  • 41598_2018_35506_MOESM5_ESM.xlsx, sheet 5
View BVdb publication page